Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Atlas Venture Associates IX, LLC (CIK 1671207) reported $11.8M across 6 reported positions in its SEC 13F filing for 2023-09-30. Largest positions: SKLZ ($5.8M, 49.69%), CHRS ($2.1M, 18.08%), SPRO ($1.6M, 13.93%), SNAP ($1.3M, 11.38%), SYBX ($496,802, 4.23%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SKLZ | SKILLZ INC | $5.8M | 49.69% | 1.1M | Hold |
| 2 | CHRS | COHERUS BIOSCIENCES INC | $2.1M | 18.08% | 568,408 | New |
| 3 | SPRO | SPERO THERAPEUTICS INC | $1.6M | 13.93% | 1.4M | Hold |
| 4 | SNAP | SNAP INC | $1.3M | 11.38% | 150,160 | Hold |
| 5 | SYBX | SYNLOGIC INC | $496,802 | 4.23% | 176,798 | New |
| 6 | NTLA | INTELLIA THERAPEUTICS INC | $316,200 | 2.69% | 10,000 | Hold |
| 7 | SURF | SURFACE ONCOLOGY INC | $0 | 0.00% | 0 | Exited |
| 8 | SYBX | SYNLOGIC INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2023-09-30